Lonza

With its headquarters in Basel and its primary sites in Europe, North America, and South Asia, Lonza is an international pharmaceutical, biotechnology, and nutritional manufacturing firm. Under that name, Lonza was established in Switzerland in 1897. The business offers specialized biopharmaceuticals, detection systems, and services for the biosciences industry and product development services to the pharmaceutical and biological sectors.

Lonza has finished selling its specialty ingredients business and is concentrating its efforts on playing a sole strategic partner in the healthcare sector. Creating a healthy planet is Lonza's stated company goal. This serves as their raison d'être and motivates them to succeed and help their patients and clients daily. Lonza has defined five strategic priorities to help them accomplish the goal: service, scope, sustainability, solutions, and speed. Each of these priorities enables Lonza to distinguish itself as a client's chosen partner.

Lonza has set a goal for 2030 to attempt and lessen its influence on the environment and natural systems, emphasizing energy, greenhouse emissions, water, and waste. The company's "Vision Zero" project seeks to make significant advancements while reducing worker accidents, environmental failures, and process failures. Site-level programs are created in accordance with the priorities and objectives of the business. Lonza creates multi-year roadmaps that reflect the nature and effects of activities over some years to enable ongoing improvement and monitoring. To address client needs and expand global regulatory requirements, the group works to provide innovative and secure technology.

Founded: 1897

Headquarters: Basel, Switzerland

Website: https://www.lonza.com/